A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/38 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 45/00 (2006.01)
Patent
CA 2298259
A composition comprising a basic drug, a drug which forms a zwitterion, or a salt of either entity, admixed with a polymer selected from hydroxypropylmethylcellulose acetate succinate (HPMCAS), cellulose acetate trimellitate (CAT), cellulose acetate phthalate (CAP), hydroxypropylcellulose acetate phthalate (HPCAP), hydroxypropylmethyl-cellulose acetate phthalate (HPMCAP), and methylcellulose acetate phthalate (MCAP). The compositions having improved solubility, hence bioavailability, in the small intestine; Processes for testing such compositions, and methods of using such compositions. The compositions comprise the basic drug, zwitterion, or salt and one or more of the aforementioned polymers. The invention further relates to a method for increasing the bioavailability of a basic or a zwitterionic drug comprising co-administering the basic drug, the zwitterionic drug, or the salt, with one or more of the aforementioned polymers.
Curatolo William John
Nightingale James Alan Schriver
Shanker Ravi Mysore
Sutton Steven Charles
Bend Research Inc.
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Basic drug compositions with enhanced bioavailability does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Basic drug compositions with enhanced bioavailability, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Basic drug compositions with enhanced bioavailability will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1605438